Synmosa Biopharma Corporation reported earnings results for the second quarter and six months ended June 30, 2023. For the second quarter, the company reported sales was TWD 1,311.1 million compared to TWD 1,057.73 million a year ago. Net income was TWD 163.63 million compared to TWD 401.26 million a year ago. Basic earnings per share from continuing operations was TWD 0.4575 compared to TWD 1.1346 a year ago. Diluted earnings per share from continuing operations was TWD 0.4575 compared to TWD 1.1254 a year ago.
For the six months, sales was TWD 2,568.83 million compared to TWD 2,024.4 million a year ago. Net income was TWD 289.69 million compared to TWD 526.4 million a year ago. Basic earnings per share from continuing operations was TWD 0.8143 compared to TWD 1.4731 a year ago. Diluted earnings per share from continuing operations was TWD 0.8143 compared to TWD 1.4731 a year ago.